A first-in-class EGFR-directed KRAS G12V selective inhibitor

Journal:

Cancer Cell

Published:

2025-06-19

DOI:

10.1016/j.ccell.2025.05.016

Affiliations:

13

Authors:

25

Go to article

Institutions	Authors	Share
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	10.583333 10.583333	0.42
UNC Lineberger Comprehensive Cancer Center, United States of America (USA)	9.583333	0.38
EnFuego Therapeutics, Inc,, United States of America (USA)	2.500000	0.10
Vanderbilt University (VU), United States of America (USA)	2.000000	0.08
Duke University Health System, United States of America (USA)	0.333333	0.01

Interested in Oncology and Carcinogenesis?